30.12.2012 Views

Pharmaceutical Manufacturing Handbook: Production and

Pharmaceutical Manufacturing Handbook: Production and

Pharmaceutical Manufacturing Handbook: Production and

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

968 ROLE OF PREFORMULATION IN DEVELOPMENT OF SOLID DOSAGE FORMS<br />

should be compared with samples stored in an inert atmosphere. Photolytic degradation<br />

is studied by exposing the sample to UV light (254 <strong>and</strong> 360 nm) for two to<br />

four weeks <strong>and</strong> observed for color fading <strong>and</strong>/or darkening [33] . Color fading may<br />

not always mean drug decomposition. It may be just a physical change which can<br />

be overcome by including dyes in the formulation. As indicated earlier, the solid -<br />

state reactions may be slow, sometimes generating only 1 – 5% of degradation products,<br />

which may be below the detection limit of HPLC [34] . A combination of<br />

qualitative <strong>and</strong> quantitative analytical tools is helpful to detect drug degradation.<br />

Nevertheless, accelerated stability studies provide an early warning of potential drug<br />

degradation <strong>and</strong> the preformulation scientist should use discretion in interpreting<br />

<strong>and</strong> sharing the results with other development teams.<br />

6.2.4.2 Solution - State Stability<br />

Detailed solution - state stability is of limited value if the fi nal anticipated dosage<br />

form is a solid. However, solution - state stability studies can predict the stability of<br />

the drug in the granulating fl uid <strong>and</strong> the GI fl uids. Solution - state reactions are<br />

faster than the solid - state reactions. This is helpful in generating degradation products<br />

through so - called forced - degradation studies for toxicological screening <strong>and</strong><br />

analytical method development. The studies are conducted by exposing the drug<br />

to extreme conditions such as 0.1 N HCl, 0.1 N NaOH, <strong>and</strong> water at 90 ° C [34] .<br />

Forced - degradation studies are useful to qualify the safety of the degradation<br />

products if it exceeds 0.1 or 0.05% of total daily dose for drugs with < 1 g or > 1 g<br />

dose/day, respectively [6] .<br />

The pH rate profi le is an important parameter that is studied in the solution state.<br />

In early preformulation studies, an approximate pH rate profi le is generated, usually<br />

including the pH encountered in salt selection <strong>and</strong> in vivo [55] . The studies are later<br />

followed with a detailed pH profi le in the whole pH range of 1 – 10. A typical pH<br />

rate profi le is shown in Figure 18 , which is useful to extract useful information on<br />

K (day –1 )<br />

2 4 6<br />

pH<br />

8 10<br />

FIGURE 18 Representative pH kinetic rate profi le. The drug shows a minimal degradation<br />

at around 2 – 4 <strong>and</strong> the degradation rate is high in alkaline pH.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!